Mtb	Mtb	NNP	O
is	be	VBZ	O
a	a	DT	O
highly	highly	RB	O
infectious	infectious	JJ	O
microbial	microbial	JJ	O
species	specie	NNS	O
that	that	WDT	O
causes	cause	VBZ	O
tuberculosis	tuberculosis	NN	O
TB	TB	NNP	O
in	in	IN	O
humans	human	NNS	O
.	.	.	O

The	the	DT	O
latest	late	JJS	O
World	World	NNP	O
Health	Health	NNP	O
Organisation	Organisation	NNP	O
report	report	NN	O
on	on	IN	O
infectious	infectious	JJ	O
diseases	disease	NNS	O
estimated	estimate	VBN	O
that	that	IN	O
annually	annually	RB	O
,	,	,	O
10	10	CD	O
million	million	CD	O
people	people	NNS	O
develop	develop	VBP	O
TB	TB	NNP	O
and	and	CC	O
1.6	1.6	CD	O
million	million	CD	O
die	die	NN	O
from	from	IN	O
the	the	DT	O
disease	disease	NN	B
.	.	.	O

Quite	quite	RB	O
worryingly	worryingly	RB	O
,	,	,	O
the	the	DT	O
same	same	JJ	O
study	study	NN	O
reported	report	VBD	O
>	>	XX	O
550	550	CD	O
000	000	CD	O
infections	infection	NNS	O
to	to	TO	O
be	be	VB	O
caused	cause	VBN	O
by	by	IN	O
rifampin	rifampin	NN	O
-	-	HYPH	O
resistant	resistant	JJ	O
strains	strain	NNS	O
that	that	WDT	O
are	be	VBP	O
unresponsive	unresponsive	JJ	O
to	to	IN	O
this	this	DT	O
first	first	JJ	O
-	-	HYPH	O
line	line	NN	O
drug	drug	NN	O
against	against	IN	O
Mtb	Mtb	NNP	O
.	.	.	O

Among	among	IN	O
these	these	DT	O
strains	strain	NNS	O
,	,	,	O
80	80	CD	O
%	%	NN	O
were	be	VBD	O
multidrug	multidrug	NN	O
-	-	HYPH	O
resistant	resistant	JJ	O
MDR	MDR	NNP	O
-	-	HYPH	O
TB	TB	NNP	O
)	)	-RRB-	B
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
there	there	EX	O
is	be	VBZ	O
an	an	DT	O
urgent	urgent	JJ	O
need	need	NN	O
for	for	IN	O
antibiotics	antibiotic	NNS	O
targeting	target	VBG	O
novel	novel	JJ	O
physiological	physiological	JJ	O
pathways	pathway	NNS	O
of	of	IN	O
Mtb	Mtb	NNP	B
.	.	.	O

Mycobacteria	Mycobacteria	NNP	O
encode	encode	VBP	O
for	for	IN	O
at	at	RB	O
least	least	RBS	O
three	three	CD	O
zinc	zinc	NN	O
-	-	HYPH	O
containing	contain	VBG	O
metalloenzyme	metalloenzyme	NNS	O
carbonic	carbonic	JJ	O
anhydrases	anhydrase	NNS	O
CAs	CAs	NNP	O
,	,	,	O
EC	EC	NNP	O
4.2.1.1	4.2.1.1	CD	O
that	that	WDT	O
belong	belong	VBP	O
to	to	IN	O
the	the	DT	O
Î²-CA	Î²-CA	NNP	O
gene	gene	NN	O
family	family	NN	B
,	,	,	B
.	.	.	O

Since	since	IN	O
the	the	DT	O
primary	primary	JJ	O
function	function	NN	O
of	of	IN	O
Î²-CAs	Î²-CAs	NNP	O
in	in	IN	O
mycobacteria	mycobacteria	NN	O
is	be	VBZ	O
to	to	TO	O
reversibly	reversibly	RB	O
catalyse	catalyse	VB	O
the	the	DT	O
hydration	hydration	NN	O
of	of	IN	O
CO2	CO2	NNP	O
to	to	TO	O
generate	generate	VB	O
HCO3â	HCO3â	NNP	O
and	and	CC	O
H+	H+	NNP	O
ions	ion	NNS	B
,	,	,	B
,	,	,	O
such	such	JJ	O
enzymes	enzyme	NNS	O
are	be	VBP	O
involved	involve	VBN	O
in	in	IN	O
a	a	DT	O
multitude	multitude	NN	O
of	of	IN	O
physiological	physiological	JJ	O
processes	process	NNS	O
closely	closely	RB	O
related	relate	VBN	O
to	to	IN	O
pH	pH	NNP	O
homeostasis	homeostasis	NN	O
,	,	,	O
biosynthetic	biosynthetic	JJ	O
processes	process	NNS	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
adaption	adaption	NN	O
to	to	IN	O
the	the	DT	O
environments	environment	NNS	B
,	,	,	B
.	.	.	O

In	in	IN	O
addition	addition	NN	O
,	,	,	O
mycobacterial	mycobacterial	NN	O
Î²-CAs	Î²-CAs	NNP	O
have	have	VBP	O
been	be	VBN	O
shown	show	VBN	O
to	to	TO	O
be	be	VB	O
essential	essential	JJ	O
for	for	IN	O
the	the	DT	O
transport	transport	NN	O
of	of	IN	O
extracellular	extracellular	NNP	O
DNA	DNA	NNP	O
eDNA	edna	NN	O
)	)	-RRB-	B
.	.	.	O

It	-PRON-	PRP	O
was	be	VBD	O
also	also	RB	O
reported	report	VBN	O
that	that	IN	O
the	the	DT	O
administration	administration	NN	O
of	of	IN	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
selective	selective	JJ	O
CA	CA	NNP	O
Inhibitor	Inhibitor	NNP	O
CAI	CAI	NNP	O
ethoxzolamide	ethoxzolamide	NN	O
EZA	EZA	NNP	O
reduced	reduce	VBN	O
transport	transport	NN	O
of	of	IN	O
eDNA	edna	NN	O
and	and	CC	O
affected	affect	VBD	O
the	the	DT	O
formation	formation	NN	O
of	of	IN	O
biofilms	biofilm	NNS	O
in	in	IN	O
non	non	JJ	O
-	-	JJ	O
tuberculous	tuberculous	JJ	O
mycobacteria	mycobacteria	NN	O
NTM	NTM	NNP	O
)	)	-RRB-	B
.	.	.	O

Another	another	DT	O
study	study	NN	O
conducted	conduct	VBN	O
on	on	IN	O
Mycobacterium	Mycobacterium	NNP	O
tuberculosis	tuberculosis	NN	O
Mtb	Mtb	NNP	O
strains	strain	VBZ	O
,	,	,	O
demonstrated	demonstrate	VBD	O
that	that	IN	O
EZA	EZA	NNP	O
inhibited	inhibit	VBD	O
the	the	DT	O
two	two	CD	O
-	-	HYPH	O
component	component	NN	O
PhoPR	PhoPR	NNP	O
regulon	regulon	NNP	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
the	the	DT	O
Esx-1	Esx-1	NNP	O
protein	protein	NN	O
secretion	secretion	NN	O
system	system	NN	O
,	,	,	O
which	which	WDT	O
are	be	VBP	O
fundamental	fundamental	JJ	O
for	for	IN	O
the	the	DT	O
virulence	virulence	NN	O
of	of	IN	O
the	the	DT	O
bacterium	bacterium	NN	B
.	.	.	O

EZA	EZA	NNP	O
also	also	RB	O
showed	show	VBD	O
efficacy	efficacy	NN	O
in	in	IN	O
infected	infected	JJ	O
macrophages	macrophage	NNS	O
and	and	CC	O
mice	mouse	NNS	O
suggesting	suggest	VBG	O
that	that	WDT	O
Î²-CAs	Î²-CAs	NNP	O
perform	perform	VBP	O
very	very	RB	O
important	important	JJ	O
roles	role	NNS	O
in	in	IN	O
mycobacterial	mycobacterial	JJ	O
infections	infection	NNS	B
,	,	,	O
and	and	CC	O
hence	hence	RB	O
present	present	JJ	O
themselves	-PRON-	PRP	O
as	as	IN	O
potential	potential	JJ	O
drug	drug	NN	O
targets	target	NNS	O
.	.	.	O

The	the	DT	O
three	three	CD	O
Mtb	Mtb	NNP	O
Î²-CAs	Î²-CAs	NNP	O
i.e.	i.e.	FW	O
Î²-CA1	î²-ca1	NN	O
,	,	,	O
Î²-CA2	î²-ca2	NN	O
and	and	CC	O
Î²-CA3	Î²-CA3	NNP	O
are	be	VBP	O
encoded	encode	VBN	O
by	by	IN	O
Rv1284	Rv1284	NNP	O
,	,	,	O
Rv3588c	rv3588c	NN	O
and	and	CC	O
Rv3273	Rv3273	NNP	O
genes	gene	NNS	O
,	,	,	O
respectively	respectively	RB	B
,	,	,	B
.	.	.	O

Among	among	IN	O
the	the	DT	O
compounds	compound	NNS	O
tested	test	VBD	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
for	for	IN	O
their	-PRON-	PRP$	O
inhibition	inhibition	NN	O
properties	property	NNS	O
against	against	IN	O
such	such	JJ	O
enzymes	enzyme	NNS	O
are	be	VBP	O
the	the	DT	O
classical	classical	JJ	O
CAIs	cai	NNS	O
of	of	IN	O
the	the	DT	O
sulphonamide	sulphonamide	JJ	O
type	type	NN	B
,	,	,	B
,	,	,	O
and	and	CC	O
the	the	DT	O
recently	recently	RB	O
reported	report	VBN	O
dithio-	dithio-	NN	O
and	and	CC	O
monothiocarbamates	monothiocarbamate	NNS	B
,	,	,	B
DTCs	dtc	NNS	O
and	and	CC	O
MTCs	mtc	NNS	O
whose	whose	WP$	O
general	general	JJ	O
structures	structure	NNS	O
are	be	VBP	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
1	1	CD	O
.	.	.	O

General	general	JJ	O
structures	structure	NNS	O
of	of	IN	O
dithiocarbamates	dithiocarbamate	NNS	O
DTC	DTC	NNP	O
and	and	CC	O
monothiocarbamates	monothiocarbamate	NNS	O
MTC	MTC	NNP	O
.	.	.	O

Both	both	DT	O
DTCs	dtc	NNS	O
and	and	CC	O
MTCs	mtc	NNS	O
have	have	VBP	O
been	be	VBN	O
explored	explore	VBN	O
,	,	,	O
with	with	IN	O
good	good	JJ	O
outcomes	outcome	NNS	O
,	,	,	O
against	against	IN	O
several	several	JJ	O
CAs	ca	NNS	O
from	from	IN	O
pathogens	pathogen	NNS	O
expressing	express	VBG	O
Î±-	Î±-	NNP	O
,	,	,	O
Î²-	î²-	UH	O
,	,	,	O
and	and	CC	O
Î´-CA	î´-ca	RB	O
enzymes	enzyme	VBZ	B
.	.	.	O

A	a	DT	O
study	study	NN	O
conducted	conduct	VBN	O
in	in	IN	O
our	-PRON-	PRP$	O
laboratory	laboratory	NN	O
showed	show	VBD	O
that	that	IN	O
a	a	DT	O
DTC	dtc	NN	O
-	-	HYPH	O
based	base	VBN	O
compound	compound	NN	O
i.e.	i.e.	FW	O
derivative	derivative	JJ	O
12	12	CD	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
not	not	RB	O
only	only	RB	O
effectively	effectively	RB	O
inhibited	inhibit	VBD	O
the	the	DT	O
Î²-CAs	Î²-CAs	NNP	O
of	of	IN	O
Mtb	Mtb	NNP	O
but	but	CC	O
also	also	RB	O
impaired	impair	VBD	O
the	the	DT	O
growth	growth	NN	O
of	of	IN	O
Mycobacterium	Mycobacterium	NNP	O
marinum	marinum	NN	O
,	,	,	O
a	a	DT	O
close	close	JJ	O
relative	relative	NN	O
of	of	IN	O
Mtb	Mtb	NNP	O
,	,	,	O
in	in	IN	O
zebrafish	zebrafish	JJ	O
larvae	larvae	JJ	B
.	.	.	O

The	the	DT	O
data	datum	NNS	O
obtained	obtain	VBN	O
by	by	IN	O
means	mean	NNS	O
of	of	IN	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
and	and	CC	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
experiments	experiment	NNS	O
involving	involve	VBG	O
DTCs	dtc	NNS	O
and	and	CC	O
MTCs	mtc	NNS	O
encouraged	encourage	VBD	O
us	-PRON-	PRP	O
to	to	TO	O
further	further	RB	O
investigate	investigate	VB	O
similar	similar	JJ	O
compounds	compound	NNS	O
against	against	IN	O
the	the	DT	O
Mtb	Mtb	NNP	O
Î²-CA3	î²-ca3	NN	O
with	with	IN	O
the	the	DT	O
aim	aim	NN	O
to	to	TO	O
find	find	VB	O
new	new	JJ	O
potential	potential	JJ	O
inhibitors	inhibitor	NNS	O
targeting	target	VBG	O
mycobacterial	mycobacterial	NN	O
Î²-CAs	Î²-CAs	NNP	B
,	,	,	B
.	.	.	O

Compounds	compound	NNS	O
1	1	CD	O
-	-	SYM	O
14	14	CD	O
considered	consider	VBN	O
in	in	IN	O
this	this	DT	O
manuscript	manuscript	NN	O
were	be	VBD	O
synthesised	synthesise	VBN	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
procedures	procedure	NNS	O
previously	previously	RB	O
reported	report	VBN	O
by	by	IN	O
some	some	DT	O
of	of	IN	O
us	-PRON-	PRP	O
,	,	,	O
and	and	CC	O
they	-PRON-	PRP	O
were	be	VBD	O
properly	properly	RB	O
characterised	characterise	VBN	O
by	by	IN	O
means	mean	NNS	O
of	of	IN	O
1H	1H	NNP	O
-	-	HYPH	O
NMR	NMR	NNP	O
,	,	,	O
13âC	13âC	NNP	O
-	-	HYPH	O
NMR	NMR	NNP	O
,	,	,	O
and	and	CC	O
mass	mass	JJ	O
spectra	spectra	NNP	O
analysis	analysis	NN	B
.	.	.	O

The	the	DT	O
CA	CA	NNP	O
-	-	HYPH	O
catalyzed	catalyze	VBN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
activity	activity	NN	O
was	be	VBD	O
assayed	assay	VBN	O
on	on	IN	O
an	an	DT	O
Applied	Applied	NNP	O
Photophysics	Photophysics	NNP	O
stopped	stop	VBD	O
-	-	HYPH	O
flow	flow	NN	O
instrument	instrument	NN	O
using	use	VBG	O
phenol	phenol	NNP	O
red	red	NNP	O
at	at	IN	O
a	a	DT	O
concentration	concentration	NN	O
of	of	IN	O
0.2âmM	0.2âmm	NN	O
as	as	IN	O
a	a	DT	O
pH	pH	NNP	O
indicator	indicator	NN	O
with	with	IN	O
20âmM	20âmm	CD	O
Hepes	Hepes	NNPS	O
pH	pH	NNP	O
7.5	7.5	CD	O
as	as	IN	O
the	the	DT	O
buffer	buffer	NN	O
,	,	,	O
20âmM	20âmm	CD	O
Na2SO4	Na2SO4	NNP	O
,	,	,	O
and	and	CC	O
following	follow	VBG	O
the	the	DT	O
initial	initial	JJ	O
rates	rate	NNS	O
of	of	IN	O
the	the	DT	O
CA	CA	NNP	O
-	-	HYPH	O
catalyzed	catalyze	VBN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
reaction	reaction	NN	O
for	for	IN	O
a	a	DT	O
period	period	NN	O
of	of	IN	O
10âââ100âs	10âââ100âs	NNP	O
and	and	CC	O
working	work	VBG	O
at	at	IN	O
the	the	DT	O
maximum	maximum	JJ	O
absorbance	absorbance	NN	O
of	of	IN	O
557ânm	557ânm	CD	B
.	.	.	O

The	the	DT	O
CO2	CO2	NNP	O
concentrations	concentration	NNS	O
ranged	range	VBD	O
from	from	IN	O
1.7	1.7	CD	O
to	to	IN	O
17âmM.	17âmm.	CD	O
For	for	IN	O
each	each	DT	O
inhibitor	inhibitor	NN	O
six	six	CD	O
traces	trace	NNS	O
of	of	IN	O
the	the	DT	O
initial	initial	JJ	O
5âââ10	5âââ10	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
reaction	reaction	NN	O
have	have	VBP	O
been	be	VBN	O
used	use	VBN	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
determine	determine	VB	O
the	the	DT	O
initial	initial	JJ	O
velocity	velocity	NN	O
.	.	.	O

The	the	DT	O
uncatalyzed	uncatalyzed	JJ	O
reaction	reaction	NN	O
rates	rate	NNS	O
were	be	VBD	O
determined	determine	VBN	O
in	in	IN	O
the	the	DT	O
same	same	JJ	O
manner	manner	NN	O
and	and	CC	O
subtracted	subtract	VBD	O
from	from	IN	O
the	the	DT	O
total	total	JJ	O
observed	observed	JJ	O
rates	rate	NNS	O
.	.	.	O

Stock	stock	NN	O
solutions	solution	NNS	O
of	of	IN	O
inhibitor	inhibitor	NN	O
0.1âmM	0.1âmm	CD	O
were	be	VBD	O
prepared	prepare	VBN	O
in	in	IN	O
distilled	distil	VBN	O
water	water	NN	O
,	,	,	O
and	and	CC	O
dilutions	dilution	NNS	O
up	up	RB	O
to	to	IN	O
0.01ânM	0.01ânm	NN	O
were	be	VBD	O
prepared	prepare	VBN	O
.	.	.	O

Solutions	solution	NNS	O
containing	contain	VBG	O
the	the	DT	O
inhibitor	inhibitor	NN	O
and	and	CC	O
enzyme	enzyme	NNS	O
were	be	VBD	O
preincubated	preincubate	VBN	O
for	for	IN	O
15âmin	15âmin	CD	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
prior	prior	RB	O
to	to	IN	O
assay	assay	NNP	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
allow	allow	VB	O
the	the	DT	O
formation	formation	NN	O
of	of	IN	O
the	the	DT	O
EâââI	EâââI	NNP	O
complex	complex	NN	O
.	.	.	O

The	the	DT	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
were	be	VBD	O
obtained	obtain	VBN	O
as	as	IN	O
nonlinear	nonlinear	JJ	O
least	least	JJS	O
-	-	HYPH	O
squares	square	NNS	O
protocols	protocol	NNS	O
using	use	VBG	O
PRISM	PRISM	NNP	O
3	3	CD	B
and	and	CC	O
are	be	VBP	O
the	the	DT	O
mean	mean	NN	O
from	from	IN	O
at	at	RB	O
least	least	RBS	O
three	three	CD	O
different	different	JJ	O
measurements	measurement	NNS	O
.	.	.	O

All	all	DT	O
hCAs	hCAs	''	O
were	be	VBD	O
recombinant	recombinant	JJ	O
ones	one	NNS	O
and	and	CC	O
were	be	VBD	O
obtained	obtain	VBN	O
in	in	IN	O
house	house	NN	B
.	.	.	O

Compounds	compound	NNS	O
1â14	1â14	CD	O
were	be	VBD	O
either	either	CC	O
dissolved	dissolve	VBN	O
in	in	IN	O
Embryonic	embryonic	JJ	O
medium	medium	NN	O
5.0âmM	5.0âmm	CD	O
NaCl	NaCl	NNP	O
,	,	,	O
0.17âmM	0.17âmm	CD	O
KCl	KCl	NNS	O
,	,	,	O
0.33âmM	0.33âmm	NN	O
CaCl2	cacl2	NN	O
,	,	,	O
0.33âmM	0.33âmm	NN	O
MgSO4	MgSO4	NNP	O
,	,	,	O
and	and	CC	O
0.1	0.1	CD	O
%	%	NN	O
w	w	NN	O
/	/	SYM	O
v	v	NN	O
Methylene	Methylene	NNP	O
Blue	Blue	NNP	O
Sigma	Sigma	NNP	O
-	-	HYPH	O
Aldrich	Aldrich	NNP	O
,	,	,	O
Germany	Germany	NNP	O
or	or	CC	O
in	in	IN	O
dimethyl	dimethyl	NNP	O
sulfoxide	sulfoxide	NN	O
DMSO	DMSO	NNP	O
Sigma	Sigma	NNP	O
-	-	HYPH	O
Aldrich	Aldrich	NNP	O
,	,	,	O
St.	St.	NNP	O
Louis	Louis	NNP	O
,	,	,	O
MO	MO	NNP	O
to	to	TO	O
prepare	prepare	VB	O
100âmM	100âmm	CD	O
stock	stock	NN	O
solutions	solution	NNS	O
.	.	.	O

Before	before	IN	O
the	the	DT	O
start	start	NN	O
of	of	IN	O
each	each	DT	O
experiment	experiment	NN	O
,	,	,	O
the	the	DT	O
series	series	NN	O
of	of	IN	O
dilutions	dilution	NNS	O
were	be	VBD	O
made	make	VBN	O
from	from	IN	O
the	the	DT	O
above	above	JJ	O
stock	stock	NN	O
in	in	IN	O
the	the	DT	O
embryonic	embryonic	JJ	O
medium	medium	NN	O
.	.	.	O

The	the	DT	O
wild	wild	JJ	O
type	type	NN	O
adult	adult	NN	O
zebrafish	zebrafish	NNP	O
AB	AB	NNP	O
strains	strain	NNS	O
were	be	VBD	O
maintained	maintain	VBN	O
at	at	IN	O
28.5âÂ	28.5ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	NNP	O

3â5	3â5	CD	O
pairs	pair	NNS	O
of	of	IN	O
male	male	JJ	O
and	and	CC	O
female	female	JJ	O
fish	fish	NNS	O
were	be	VBD	O
moved	move	VBN	O
to	to	IN	O
breeding	breed	VBG	O
tanks	tank	NNS	O
overnight	overnight	RB	B
.	.	.	O

Next	next	JJ	O
morning	morning	NN	O
,	,	,	O
1â2-h	1â2-h	VBZ	O
post	post	NNP	O
fertilisation	fertilisation	NNP	O
hpf	hpf	NNP	O
,	,	,	O
embryos	embryo	NNS	O
were	be	VBD	O
collected	collect	VBN	O
in	in	IN	O
a	a	DT	O
sieve	sieve	NN	O
and	and	CC	O
rinsed	rinse	VBN	O
with	with	IN	O
embryonic	embryonic	JJ	O
medium	medium	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
collected	collect	VBN	O
embryos	embryo	NNS	O
were	be	VBD	O
maintained	maintain	VBN	O
in	in	IN	O
an	an	DT	O
incubator	incubator	NN	O
at	at	IN	O
28.5âÂ	28.5ââ	CD	O
°	°	,	O
C	C	NNP	O
overnight	overnight	JJ	B
.	.	.	O

The	the	DT	O
toxicity	toxicity	NN	O
evaluation	evaluation	NN	O
studies	study	NNS	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
were	be	VBD	O
initiated	initiate	VBN	O
with	with	IN	O
fish	fish	NN	O
embryos	embryo	NNS	O
24-hpf	24-hpf	CD	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
fish	fish	NN	O
experiments	experiment	NNS	O
were	be	VBD	O
performed	perform	VBN	O
at	at	IN	O
the	the	DT	O
zebrafish	zebrafish	JJ	O
core	core	NN	O
facility	facility	NN	O
of	of	IN	O
Tampere	Tampere	NNP	O
University	University	NNP	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
protocol	protocol	NN	O
used	use	VBN	O
in	in	IN	O
our	-PRON-	PRP$	O
laboratory	laboratory	NN	B
.	.	.	O

The	the	DT	O
research	research	NN	O
unit	unit	NN	O
at	at	IN	O
Tampere	Tampere	NNP	O
University	University	NNP	O
has	have	VBZ	O
an	an	DT	O
established	established	JJ	O
zebrafish	zebrafish	JJ	O
core	core	NN	O
facility	facility	NN	O
authorised	authorise	VBN	O
by	by	IN	O
the	the	DT	O
National	National	NNP	O
Animal	Animal	NNP	O
Experiment	Experiment	NNP	O
Board	Board	NNP	O
ESAVI/7975/04.10.05/2016	esavi/7975/04.10.05/2016	RB	O
.	.	.	O

The	the	DT	O
experiments	experiment	NNS	O
using	use	VBG	O
developing	develop	VBG	O
zebrafish	zebrafish	JJ	O
embryos	embryo	NNS	O
were	be	VBD	O
performed	perform	VBN	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
Provincial	Provincial	NNP	O
Government	Government	NNP	O
of	of	IN	O
Eastern	Eastern	NNP	O
Finland	Finland	NNP	O
Province	Province	NNP	O
Social	Social	NNP	O
and	and	CC	O
Health	Health	NNP	O
Department	Department	NNP	O
Tampere	Tampere	NNP	O
Regional	Regional	NNP	O
Service	Service	NNP	O
Unit	Unit	NNP	O
protocol	protocol	NN	O
#	#	$	O
LSLH-2007â7254	LSLH-2007â7254	NNP	O
/	/	SYM	O
Ym-23	Ym-23	NNP	O
.	.	.	O

Care	care	NN	O
was	be	VBD	O
taken	take	VBN	O
to	to	TO	O
ameliorate	ameliorate	VB	O
suffering	suffering	NN	O
by	by	IN	O
euthanizing	euthanize	VBG	O
the	the	DT	O
5	5	CD	O
dpf	dpf	NN	O
larvae	larvae	VBN	O
by	by	IN	O
prolonged	prolonged	JJ	O
immersion	immersion	NN	O
in	in	IN	O
a	a	DT	O
petri	petri	JJ	O
dish	dish	NN	O
containing	contain	VBG	O
an	an	DT	O
overdose	overdose	NN	O
of	of	IN	O
Tricaine	Tricaine	NNP	O
Sigma	Sigma	NNP	O
-	-	HYPH	O
Aldrich	Aldrich	NNP	O
,	,	,	O
St.	St.	NNP	O
Louis	Louis	NNP	O
,	,	,	O
MO	MO	NNP	O
before	before	IN	O
fixing	fix	VBG	O
in	in	IN	O
buffered	buffered	JJ	O
formaldehyde	formaldehyde	NN	O
for	for	IN	O
histochemical	histochemical	JJ	O
analysis	analysis	NN	O
.	.	.	O

The	the	DT	O
LC50	LC50	NNP	O
values	value	NNS	O
for	for	IN	O
all	all	PDT	O
the	the	DT	O
MTC	MTC	NNP	O
and	and	CC	O
DTC	DTC	NNP	O
compounds	compound	NNS	O
were	be	VBD	O
determined	determine	VBN	O
using	use	VBG	O
24-hpf	24-hpf	CD	O
embryos	embryo	NNS	O
with	with	IN	O
10â12	10â12	CD	O
different	different	JJ	O
concentrations	concentration	NNS	O
for	for	IN	O
each	each	DT	O
compound	compound	NN	O
.	.	.	O

For	for	IN	O
every	every	DT	O
concentration	concentration	NN	O
of	of	IN	O
the	the	DT	O
inhibitor	inhibitor	NN	O
,	,	,	O
we	-PRON-	PRP	O
used	use	VBD	O
30	30	CD	O
24-hpf	24-hpf	CD	O
embryos	embryo	NNS	B
,	,	,	B
.	.	.	O

For	for	IN	O
each	each	DT	O
compound	compound	NN	O
,	,	,	O
the	the	DT	O
fish	fish	NN	O
were	be	VBD	O
exposed	expose	VBN	O
to	to	IN	O
different	different	JJ	O
concentrations	concentration	NNS	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
rangeing	range	VBG	O
from	from	IN	O
5âÎ¼M	5âî¼m	CD	O
to	to	IN	O
2.5âmM.	2.5âmm.	CD	O
Dose	Dose	NNP	O
response	response	NN	O
curve	curve	NN	O
DRC	DRC	NNP	O
was	be	VBD	O
calculated	calculate	VBN	O
using	use	VBG	O
DRM	DRM	NNP	O
of	of	IN	O
the	the	DT	O
DRC	DRC	NNP	O
R	r	NN	O
package	package	NN	B
.	.	.	O

The	the	DT	O
control	control	NN	O
group	group	NN	O
larvae	larvae	NNP	O
constituted	constitute	VBD	O
an	an	DT	O
equal	equal	JJ	O
number	number	NN	O
of	of	IN	O
larvae	larvae	NNP	O
not	not	RB	O
treated	treat	VBN	O
with	with	IN	O
any	any	DT	O
inhibitor	inhibitor	NN	O
compound	compound	NN	O
and	and	CC	O
the	the	DT	O
larvae	larva	NNS	O
that	that	WDT	O
were	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
1	1	CD	O
%	%	NN	O
of	of	IN	O
DMSO	DMSO	NNP	O
.	.	.	O

Toxicological	toxicological	JJ	O
evaluation	evaluation	NN	O
studies	study	NNS	O
were	be	VBD	O
performed	perform	VBN	O
in	in	IN	O
24-well	24-well	CD	O
plates	plate	NNS	O
Corning	corn	VBG	O
V	v	NN	O
R	r	NN	O
Co	co	NN	O
-	-	NN	O
star	star	NN	O
V	v	NN	O
R	r	NN	O
cell	cell	NN	O
culture	culture	NN	O
plates	plate	NNS	O
.	.	.	O

One	one	CD	O
or	or	CC	O
two	two	CD	O
24-hpf	24-hpf	CD	O
embryos	embryo	NNS	O
in	in	IN	O
were	be	VBD	O
placed	place	VBN	O
per	per	IN	O
well	well	RB	O
in	in	IN	O
1âmL	1âml	CD	O
of	of	IN	O
embryonic	embryonic	JJ	O
medium	medium	NN	O
containing	contain	VBG	O
a	a	DT	O
diluted	diluted	JJ	O
inhibitor	inhibitor	NN	O
.	.	.	O

A	a	DT	O
minimum	minimum	NN	O
of	of	IN	O
three	three	CD	O
sets	set	NNS	O
of	of	IN	O
experiments	experiment	NNS	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
for	for	IN	O
each	each	DT	O
inhibitor	inhibitor	NN	O
.	.	.	O

Mortality	mortality	NN	O
of	of	IN	O
the	the	DT	O
larvae	larvae	NN	O
was	be	VBD	O
checked	check	VBN	O
every	every	DT	O
24âh	24âh	CD	O
until	until	IN	O
5âdays	5âdays	CD	O
after	after	IN	O
exposure	exposure	NN	O
to	to	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
.	.	.	O

After	after	IN	O
exposure	exposure	NN	O
to	to	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
,	,	,	O
we	-PRON-	PRP	O
evaluated	evaluate	VBD	O
the	the	DT	O
effects	effect	NNS	O
of	of	IN	O
these	these	DT	O
inhibitors	inhibitor	NNS	O
on	on	IN	O
the	the	DT	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
and	and	CC	O
analysed	analyse	VBD	O
eight	eight	CD	O
phenotypic	phenotypic	JJ	O
parameters	parameter	NNS	O
:	:	:	O
1	1	LS	O
mortality	mortality	NN	O
,	,	,	O
2	2	LS	O
hatching	hatching	NN	O
,	,	,	O
3	3	LS	O
oedema	oedema	NN	O
,	,	,	O
4	4	LS	O
swimming	swimming	NN	O
pattern	pattern	NN	O
,	,	,	O
5	5	LS	O
yolk	yolk	NN	O
sack	sack	NN	O
utilisation	utilisation	NN	O
,	,	,	O
6	6	LS	O
heartbeat	heartbeat	NN	O
,	,	,	O
7	7	LS	O
body	body	NN	O
shape	shape	NN	O
,	,	,	O
and	and	CC	O
8)	8)	CD	O
swim	swim	VB	O
bladder	bladder	NN	O
development	development	NN	O
.	.	.	O

The	the	DT	O
images	image	NNS	O
of	of	IN	O
the	the	DT	O
developing	develop	VBG	O
larvae	larva	NNS	O
were	be	VBD	O
taken	take	VBN	O
using	use	VBG	O
a	a	DT	O
Lumar	Lumar	NNP	O
V1.12	V1.12	NNP	O
microscope	microscope	NN	O
attached	attach	VBD	O
to	to	IN	O
a	a	DT	O
camera	camera	NN	O
Carl	Carl	NNP	O
Zeiss	Zeiss	NNP	O
MicroImaging	MicroImaging	NNP	O
GmbH	GmbH	NNP	O
,	,	,	O
GÃ¶ttingen	GÃ¶ttingen	NNP	O
,	,	,	O
Germany	Germany	NNP	O
.	.	.	O

The	the	DT	O
images	image	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
with	with	IN	O
AxioVision	AxioVision	NNP	O
software	software	NN	O
versions	version	NNS	O
4.7	4.7	CD	O
and	and	CC	O
4.8	4.8	CD	O
as	as	IN	O
described	describe	VBN	O
in	in	IN	O
our	-PRON-	PRP$	O
standard	standard	JJ	O
protocol	protocol	NN	O
for	for	IN	O
assessment	assessment	NN	O
of	of	IN	O
toxicity	toxicity	NN	O
and	and	CC	O
safety	safety	NN	O
of	of	IN	O
the	the	DT	O
chemical	chemical	NN	O
compounds	compound	NNS	B
.	.	.	O

The	the	DT	O
swim	swim	NN	O
pattern	pattern	NN	O
of	of	IN	O
the	the	DT	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
was	be	VBD	O
studied	study	VBN	O
after	after	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
exposure	exposure	NN	O
to	to	IN	O
these	these	DT	O
inhibitors	inhibitor	NNS	O
.	.	.	O

For	for	IN	O
the	the	DT	O
analyses	analysis	NNS	O
of	of	IN	O
swim	swim	NN	O
pattern	pattern	NN	O
,	,	,	O
about	about	RB	O
10â15	10â15	CD	O
zebrafish	zebrafish	NNP	O
larvae	larva	NNS	O
were	be	VBD	O
placed	place	VBN	O
in	in	IN	O
a	a	DT	O
35âmm	35âmm	CD	O
X	x	NN	O
15âmm	15âmm	CD	O
petri	petri	NN	O
dish	dish	NN	O
containing	contain	VBG	O
embryonic	embryonic	JJ	O
medium	medium	NN	O
and	and	CC	O
the	the	DT	O
larvae	larva	NNS	O
were	be	VBD	O
allowed	allow	VBN	O
to	to	TO	O
settle	settle	VB	O
in	in	IN	O
the	the	DT	O
petri	petri	JJ	O
dish	dish	NN	O
for	for	IN	O
1âmin	1âmin	NNS	O
.	.	.	O

The	the	DT	O
movement	movement	NN	O
of	of	IN	O
the	the	DT	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
was	be	VBD	O
observed	observe	VBN	O
under	under	IN	O
the	the	DT	O
microscope	microscope	NN	O
for	for	IN	O
1âmin	1âmin	CD	O
.	.	.	O

The	the	DT	O
swim	swim	NN	O
patterns	pattern	NNS	O
were	be	VBD	O
compared	compare	VBN	O
with	with	IN	O
the	the	DT	O
control	control	NN	O
group	group	NN	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
that	that	WDT	O
were	be	VBD	O
not	not	RB	O
treated	treat	VBN	O
with	with	IN	O
any	any	DT	O
inhibitor	inhibitor	NN	O
.	.	.	O

The	the	DT	O
histochemical	histochemical	JJ	O
analyses	analysis	NNS	O
were	be	VBD	O
done	do	VBN	O
to	to	TO	O
assess	assess	VB	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
inhibitors	inhibitor	NNS	O
on	on	IN	O
the	the	DT	O
morphology	morphology	NN	O
of	of	IN	O
tissues	tissue	NNS	O
of	of	IN	O
the	the	DT	O
larvae	larva	NNS	O
that	that	WDT	O
were	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
different	different	JJ	O
concentrations	concentration	NNS	O
of	of	IN	O
inhibitors	inhibitor	NNS	O
.	.	.	O

The	the	DT	O
control	control	NN	O
group	group	NN	O
larvae	larvae	NNP	O
were	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
embryonic	embryonic	JJ	O
medium	medium	NN	O
alone	alone	RB	O
or	or	CC	O
with	with	IN	O
1	1	CD	O
%	%	NN	O
DMSO	DMSO	NNS	O
in	in	IN	O
embryonic	embryonic	JJ	O
medium	medium	NN	O
.	.	.	O

After	after	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
treatment	treatment	NN	O
the	the	DT	O
larvae	larva	NNS	O
were	be	VBD	O
washed	wash	VBN	O
with	with	IN	O
phosphate	phosphate	NN	O
buffered	buffered	JJ	O
saline	saline	NN	O
PBS	PBS	NNP	O
and	and	CC	O
immersed	immerse	VBN	O
in	in	IN	O
excess	excess	JJ	O
amounts	amount	NNS	O
of	of	IN	O
Tricaine	Tricaine	NNP	O
to	to	TO	O
anaesthetize	anaesthetize	VB	O
them	-PRON-	PRP	O
.	.	.	O

The	the	DT	O
larvae	larva	NNS	O
were	be	VBD	O
transferred	transfer	VBN	O
to	to	IN	O
a	a	DT	O
1.5âmL	1.5âml	CD	O
microcentrifuge	microcentrifuge	NN	O
tube	tube	NN	O
and	and	CC	O
fixed	fix	VBN	O
in	in	IN	O
buffered	buffer	VBN	O
formaldehyde	formaldehyde	NN	O
4	4	CD	O
%	%	NN	O
formaldehyde	formaldehyde	NN	O
solution	solution	NN	O
,	,	,	O
pH	pH	NNP	O
6.9	6.9	CD	O
in	in	IN	O
PBS	PBS	NNP	O
for	for	IN	O
3âh	3âh	CD	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
or	or	CC	O
overnight	overnight	RB	O
at	at	IN	O
4âÂ	4ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

After	after	IN	O
the	the	DT	O
fixation	fixation	NN	O
,	,	,	O
the	the	DT	O
larvae	larva	NNS	O
were	be	VBD	O
transferred	transfer	VBN	O
to	to	IN	O
70	70	CD	O
%	%	NN	O
ethanol	ethanol	NN	O
and	and	CC	O
stored	store	VBD	O
at	at	IN	O
4âÂ	4ââ	CD	O
°	°	,	O
C	C	NNP	O
before	before	IN	O
embedding	embed	VBG	O
in	in	IN	O
paraffin	paraffin	NN	O
.	.	.	O

The	the	DT	O
samples	sample	NNS	O
were	be	VBD	O
then	then	RB	O
sectioned	section	VBN	O
into	into	IN	O
5âÎ¼m	5âî¼m	DT	O
thin	thin	JJ	O
slices	slice	NNS	O
for	for	IN	O
the	the	DT	O
histochemical	histochemical	JJ	O
staining	staining	NN	O
.	.	.	O

The	the	DT	O
sections	section	NNS	O
were	be	VBD	O
deparaffinized	deparaffinize	VBN	O
in	in	IN	O
xylene	xylene	NNP	O
,	,	,	O
rehydrated	rehydrate	VBN	O
in	in	IN	O
an	an	DT	O
alcohol	alcohol	NN	O
series	series	NN	O
,	,	,	O
and	and	CC	O
stained	stain	VBN	O
with	with	IN	O
Mayer	Mayer	NNP	O
's	's	POS	O
Haematoxylin	Haematoxylin	NNP	O
and	and	CC	O
Eosin	Eosin	NNP	O
Y	Y	NNP	O
both	both	DT	O
from	from	IN	O
Sigma	Sigma	NNP	O
-	-	HYPH	O
Aldrich	Aldrich	NNP	O
.	.	.	O

After	after	IN	O
dehydration	dehydration	NN	O
,	,	,	O
the	the	DT	O
slides	slide	NNS	O
were	be	VBD	O
mounted	mount	VBN	O
with	with	IN	O
EntellanÂ	EntellanÂ	NNP	O
®	®	.	O
Neu	Neu	NNP	O
Merck	Merck	NNP	O
;	;	:	O
Darmstadt	Darmstadt	NNP	O
,	,	,	O
Germany	Germany	NNP	O
.	.	.	O

The	the	DT	O
slides	slide	NNS	O
containing	contain	VBG	O
the	the	DT	O
tissues	tissue	NNS	O
were	be	VBD	O
examined	examine	VBN	O
for	for	IN	O
morphological	morphological	JJ	O
changes	change	NNS	O
and	and	CC	O
photographed	photograph	VBD	O
using	use	VBG	O
a	a	DT	O
Nikon	Nikon	NNP	O
Microphot	Microphot	NNP	O
microscope	microscope	NN	O
Nikon	Nikon	NNP	O
Microphot-	Microphot-	NNP	O
FXA	FXA	NNP	O
,	,	,	O
Japan	Japan	NNP	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
procedures	procedure	NNS	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
unless	unless	IN	O
stated	state	VBN	O
otherwise	otherwise	RB	O
.	.	.	O

The	the	DT	O
main	main	JJ	O
structural	structural	JJ	O
differences	difference	NNS	O
among	among	IN	O
the	the	DT	O
compounds	compound	NNS	O
tested	test	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
are	be	VBP	O
related	relate	VBN	O
to	to	IN	O
the	the	DT	O
metal	metal	NN	O
binding	bind	VBG	O
moieties	moiety	NNS	O
of	of	IN	O
CAs	ca	NNS	O
.	.	.	O

The	the	DT	O
compounds	compound	NNS	O
included	include	VBD	O
both	both	DT	O
monothiocarbamates	monothiocarbamate	NNS	O
MTCs	MTCs	NNPS	O
1â7	1â7	CD	O
and	and	CC	O
dithiocarbamates	dithiocarbamate	NNS	O
DTCs	DTCs	NNPS	O
8â14	8â14	CD	O
Figure	figure	NN	O
2	2	CD	O
.	.	.	O

Chemical	chemical	NN	O
structures	structure	NNS	O
of	of	IN	O
MTCs	mtc	NNS	O
1	1	CD	O
-	-	SYM	O
7	7	CD	O
and	and	CC	O
DTCs	dtc	NNS	O
8	8	CD	O
-	-	SYM	O
14	14	CD	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
efficiently	efficiently	RB	O
explore	explore	VB	O
the	the	DT	O
inhibition	inhibition	NN	O
potencies	potency	NNS	O
of	of	IN	O
the	the	DT	O
MTC	MTC	NNP	O
and	and	CC	O
DTC	dtc	NN	O
binding	bind	VBG	O
moieties	moiety	NNS	O
on	on	IN	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
,	,	,	O
we	-PRON-	PRP	O
decided	decide	VBD	O
to	to	TO	O
consider	consider	VB	O
small	small	JJ	O
size	size	NN	O
and	and	CC	O
lined	line	VBN	O
-	-	HYPH	O
shaped	shape	VBN	O
scaffolds	scaffold	NNS	O
lacking	lack	VBG	O
any	any	DT	O
bulky	bulky	JJ	O
substitution	substitution	NN	O
.	.	.	O

Such	such	PDT	O
an	an	DT	O
approach	approach	NN	O
was	be	VBD	O
also	also	RB	O
justified	justify	VBN	O
by	by	IN	O
the	the	DT	O
narrower	narrow	JJR	O
size	size	NN	O
of	of	IN	O
the	the	DT	O
Î²	Î²	NNP	O
CAâs	CAâs	NNP	O
cavities	cavity	NNS	O
when	when	WRB	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
Î±	î±	JJ	O
ones	one	NNS	B
.	.	.	O

As	as	IN	O
reported	report	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
2	2	CD	O
almost	almost	RB	O
all	all	DT	O
compounds	compound	NNS	O
responded	respond	VBD	O
to	to	IN	O
such	such	PDT	O
a	a	DT	O
rule	rule	NN	O
and	and	CC	O
the	the	DT	O
only	only	JJ	O
exceptions	exception	NNS	O
were	be	VBD	O
the	the	DT	O
3-carboxy	3-carboxy	CD	O
substituted	substituted	JJ	O
piperazine	piperazine	NN	O
13	13	CD	O
and	and	CC	O
the	the	DT	O
bicyclo[2.2.2]octan-2-amine	bicyclo[2.2.2]octan-2-amine	NNP	O
14	14	CD	O
.	.	.	O

Compounds	compound	NNS	O
1â14	1â14	CD	O
were	be	VBD	O
tested	test	VBN	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
for	for	IN	O
their	-PRON-	PRP$	O
inhibitory	inhibitory	JJ	O
properties	property	NNS	O
against	against	IN	O
the	the	DT	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
and	and	CC	O
the	the	DT	O
data	datum	NNS	O
are	be	VBP	O
reported	report	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
.	.	.	O

Inhibition	inhibition	NN	O
data	datum	NNS	O
of	of	IN	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
and	and	CC	O
human	human	JJ	O
CA	CA	NNP	O
isoforms	isoform	NNS	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
for	for	IN	O
compounds	compound	NNS	O
1â14	1â14	CD	O
,	,	,	O
determined	determine	VBN	O
by	by	IN	O
the	the	DT	O
stopped	stop	VBN	O
-	-	HYPH	O
flow	flow	NN	O
CO2	CO2	NNP	O
hydrase	hydrase	NN	O
assay	assay	NN	B
,	,	,	O
using	use	VBG	O
acetazolamide	acetazolamide	NN	O
AAZ	AAZ	NNP	O
as	as	IN	O
a	a	DT	O
standard	standard	JJ	O
drug	drug	NN	O
.	.	.	O

Mean	mean	VB	O
from	from	IN	O
3	3	CD	O
different	different	JJ	O
assays	assay	NNS	O
,	,	,	O
by	by	IN	O
a	a	DT	O
stopped	stop	VBN	O
flow	flow	NN	O
technique	technique	NN	O
errors	error	NNS	O
were	be	VBD	O
in	in	IN	O
the	the	DT	O
range	range	NN	O
of	of	IN	O
Â±	Â±	NNP	O
5â10	5â10	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
reported	report	VBN	O
values	value	NNS	O
.	.	.	O

The	the	DT	O
kinetic	kinetic	JJ	O
data	datum	NNS	O
reported	report	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
clearly	clearly	RB	O
showed	show	VBN	O
that	that	IN	O
among	among	IN	O
the	the	DT	O
MTCs	mtc	NNS	O
tested	test	VBD	O
the	the	DT	O
derivative	derivative	NN	O
4	4	CD	O
was	be	VBD	O
the	the	DT	O
most	most	RBS	O
potent	potent	JJ	O
compound	compound	NN	O
in	in	IN	O
inhibiting	inhibit	VBG	O
the	the	DT	O
Mtb	Mtb	NNP	O
Î²-CA3	î²-ca3	NN	O
with	with	IN	O
a	a	DT	O
KI	KI	NNP	O
value	value	NN	O
of	of	IN	O
83.3ânM	83.3ânm	CD	O
,	,	,	O
followed	follow	VBN	O
by	by	IN	O
the	the	DT	O
phenylethyl	phenylethyl	NN	O
5	5	CD	O
KI	KI	NNP	O
93.0ânM	93.0ânM	NNP	O
and	and	CC	O
its	-PRON-	PRP$	O
3,4-dimethoxyphenylethyl	3,4-dimethoxyphenylethyl	CD	O
derivative	derivative	JJ	O
7	7	CD	O
KI	KI	NNP	O
97.9ânM	97.9ânM	NNP	O
,	,	,	O
and	and	CC	O
thus	thus	RB	O
slightly	slightly	RB	O
more	more	RBR	O
potent	potent	JJ	O
than	than	IN	O
the	the	DT	O
reference	reference	NN	O
CAI	CAI	NNP	O
AAZ	AAZ	NNP	O
KI	KI	NNP	O
104ânM	104ânm	CD	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
other	other	JJ	O
remaining	remain	VBG	O
MTCs	mtc	NNS	O
i.e.	i.e.	FW	O
1â3	1â3	CD	O
and	and	CC	O
6	6	CD	O
were	be	VBD	O
high	high	JJ	O
nanomolar	nanomolar	JJ	O
range	range	NN	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
the	the	DT	O
Î²-CA3	î²-ca3	NN	O
with	with	IN	O
KI	KI	NNP	O
values	value	NNS	O
spanning	span	VBG	O
between	between	IN	O
558.6	558.6	CD	O
and	and	CC	O
812.0ânM.	812.0ânm.	CD	O
Interestingly	interestingly	RB	O
MTCs	mtc	NNS	O
4	4	CD	O
,	,	,	O
5	5	CD	O
and	and	CC	O
7	7	CD	O
were	be	VBD	O
ineffective	ineffective	JJ	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
the	the	DT	O
hCA	hca	NN	O
I	-PRON-	PRP	O
KIs	KIs	NNP	O
>	>	XX	O
2000	2000	CD	O
for	for	IN	O
compounds	compound	NNS	O
4	4	CD	O
and	and	CC	O
5	5	CD	O
,	,	,	O
891ânM	891ânm	CD	O
for	for	IN	O
7	7	CD	O
respectively	respectively	RB	O
.	.	.	O

Conversely	conversely	RB	O
,	,	,	O
compounds	compound	VBZ	O
4	4	CD	O
,	,	,	O
5	5	CD	O
and	and	CC	O
7	7	CD	O
showed	show	VBD	O
good	good	JJ	O
inhibition	inhibition	NN	O
data	datum	NNS	O
on	on	IN	O
hCA	hCA	NNP	O
II	II	NNP	O
being	be	VBG	O
up	up	IN	O
to	to	TO	O
3.7	3.7	CD	O
fold	fold	VB	O
more	more	RBR	O
potent	potent	JJ	O
KIs	ki	NNS	O
of	of	IN	O
43.6	43.6	CD	O
,	,	,	O
43.7	43.7	CD	O
and	and	CC	O
26.7ânM	26.7ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

An	an	DT	O
analogous	analogous	JJ	O
kinetic	kinetic	JJ	O
trend	trend	NN	O
was	be	VBD	O
observed	observe	VBN	O
for	for	IN	O
the	the	DT	O
remaining	remain	VBG	O
MTCs	mtc	NNS	O
1	1	CD	O
,	,	,	O
3	3	CD	O
and	and	CC	O
6	6	CD	O
which	which	WDT	O
were	be	VBD	O
quite	quite	RB	O
effective	effective	JJ	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
the	the	DT	O
hCA	hca	NN	O
II	II	NNP	O
over	over	IN	O
the	the	DT	O
hCA	hca	NN	O
I	-PRON-	PRP	O
isoform	isoform	VBP	O
.	.	.	O

The	the	DT	O
only	only	JJ	O
exception	exception	NN	O
is	be	VBZ	O
represented	represent	VBN	O
by	by	IN	O
the	the	DT	O
MTC	MTC	NNP	O
based	base	VBN	O
morpholine	morpholine	NNP	O
2	2	CD	O
which	which	WDT	O
showed	show	VBD	O
high	high	JJ	O
nanomolar	nanomolar	NN	O
KI	KI	NNP	O
value	value	NN	O
on	on	IN	O
the	the	DT	O
hCA	hca	NN	O
I	-PRON-	PRP	O
KI	KI	NNP	O
569ânM	569ânm	CD	O
and	and	CC	O
no	no	DT	O
effects	effect	NNS	O
on	on	IN	O
the	the	DT	O
hCA	hca	NN	O
II	II	NNP	O
isoform	isoform	NN	O
KI	KI	NNP	O
>	>	XX	O
2000	2000	CD	O
.	.	.	O

As	as	IN	O
for	for	IN	O
the	the	DT	O
isosteric	isosteric	JJ	O
DTC	DTC	NNP	O
derivatives	derivative	NNS	O
8â14	8â14	CD	O
a	a	DT	O
rather	rather	RB	O
different	different	JJ	O
kinetic	kinetic	NNP	O
profile	profile	NN	O
was	be	VBD	O
observed	observe	VBN	O
.	.	.	O

For	for	IN	O
instance	instance	NN	O
,	,	,	O
the	the	DT	O
morpholine	morpholine	NNP	O
DTC	DTC	NNP	O
9	9	CD	O
was	be	VBD	O
the	the	DT	O
most	most	RBS	O
potent	potent	JJ	O
inhibitor	inhibitor	NN	O
within	within	IN	O
the	the	DT	O
series	series	NN	O
against	against	IN	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
KI	KI	NNP	O
of	of	IN	O
2.4ânM	2.4ânm	CD	O
and	and	CC	O
quite	quite	RB	O
interestingly	interestingly	RB	O
it	-PRON-	PRP	O
was	be	VBD	O
311.5	311.5	CD	O
fold	fold	VB	O
more	more	RBR	O
potent	potent	JJ	O
when	when	WRB	O
compared	compare	VBN	O
to	to	IN	O
its	-PRON-	PRP$	O
MTC	MTC	NNP	O
analogous	analogous	JJ	O
compound	compound	NN	O
2	2	CD	O
see	see	VB	O
Table	table	NN	O
1	1	CD	O
.	.	.	O

A	a	DT	O
similar	similar	JJ	O
kinetic	kinetic	JJ	O
trend	trend	NN	O
was	be	VBD	O
reported	report	VBN	O
also	also	RB	O
for	for	IN	O
the	the	DT	O
bis	bis	JJ	O
-	-	HYPH	O
piperazine	piperazine	NN	O
derivative	derivative	JJ	O
DTC	DTC	NNP	O
10	10	CD	O
in	in	IN	O
comparison	comparison	NN	O
to	to	IN	O
its	-PRON-	PRP$	O
MTC	MTC	NNP	O
counterpart	counterpart	NN	O
3	3	CD	O
with	with	IN	O
the	the	DT	O
former	former	JJ	O
being	be	VBG	O
101.5	101.5	CD	O
fold	fold	VB	O
more	more	RBR	O
potent	potent	JJ	O
on	on	IN	O
the	the	DT	O
Î²-CA3	î²-ca3	NN	O
KIs	ki	NNS	O
of	of	IN	O
8.0	8.0	CD	O
and	and	CC	O
812.0ânM	812.0ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

An	an	DT	O
opposite	opposite	JJ	O
kinetic	kinetic	JJ	O
trend	trend	NN	O
was	be	VBD	O
reported	report	VBN	O
for	for	IN	O
the	the	DT	O
DTC	DTC	NNP	O
11	11	CD	O
which	which	WDT	O
was	be	VBD	O
ineffective	ineffective	JJ	O
on	on	IN	O
the	the	DT	O
Î²-CA3	î²-ca3	NN	O
,	,	,	O
whereas	whereas	IN	O
its	-PRON-	PRP$	O
MTC	MTC	NNP	O
derivative	derivative	NN	O
6	6	CD	O
was	be	VBD	O
a	a	DT	O
high	high	JJ	O
nanomolar	nanomolar	JJ	O
inhibitor	inhibitor	NN	O
KIs	ki	NNS	O
of	of	IN	O
>	>	XX	O
2000	2000	CD	O
and	and	CC	O
780.7ânM	780.7ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Among	among	IN	O
the	the	DT	O
DTCs	dtc	NNS	O
reported	report	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
,	,	,	O
the	the	DT	O
N	N	NNP	O
-	-	HYPH	O
methylpiperazine	methylpiperazine	NNP	O
12	12	CD	O
was	be	VBD	O
the	the	DT	O
second	second	JJ	O
most	most	RBS	O
potent	potent	JJ	O
inhibitor	inhibitor	NN	O
against	against	IN	O
the	the	DT	O
Î²-CA3	î²-ca3	NN	O
just	just	RB	O
after	after	IN	O
the	the	DT	O
morpholine	morpholine	NN	O
derivative	derivative	JJ	O
9	9	CD	O
KI	KI	NNP	O
of	of	IN	O
2.6	2.6	CD	O
and	and	CC	O
2.4ânM	2.4ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
structural	structural	JJ	O
differences	difference	NNS	O
between	between	IN	O
9	9	CD	O
and	and	CC	O
12	12	CD	O
i.e.	i.e.	FW	O
an	an	DT	O
oxygen	oxygen	NN	O
and	and	CC	O
an	an	DT	O
N	N	NNP	O
-	-	HYPH	O
methyl	methyl	NN	O
moiety	moiety	NN	O
at	at	IN	O
4-position	4-position	CD	O
of	of	IN	O
the	the	DT	O
scaffold	scaffold	NN	O
,	,	,	O
respectively	respectively	RB	O
did	do	VBD	O
not	not	RB	O
affect	affect	VB	O
the	the	DT	O
inhibition	inhibition	NN	O
potencies	potency	NNS	O
against	against	IN	O
the	the	DT	O
Î²-CA3	Î²-CA3	NNP	O
,	,	,	O
whereas	whereas	IN	O
they	-PRON-	PRP	O
proved	prove	VBD	O
crucial	crucial	JJ	O
for	for	IN	O
the	the	DT	O
inhibition	inhibition	NN	O
of	of	IN	O
the	the	DT	O
hCAs	hcas	XX	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
.	.	.	O

As	as	IN	O
reported	report	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
the	the	DT	O
morpholine	morpholine	NN	O
derivative	derivative	JJ	O
9	9	CD	O
was	be	VBD	O
a	a	DT	O
sub	sub	JJ	O
-	-	JJ	O
nanomolar	nanomolar	JJ	O
inhibitor	inhibitor	NN	O
of	of	IN	O
the	the	DT	O
hCAs	hcas	XX	O
reported	reported	JJ	O
KIs	ki	NNS	O
of	of	IN	O
0.88	0.88	CD	O
and	and	CC	O
0.95ânM	0.95ânm	CD	O
for	for	IN	O
the	the	DT	O
hCA	hca	NN	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
,	,	,	O
respectively	respectively	RB	O
,	,	,	O
whereas	whereas	IN	O
the	the	DT	O
N	N	NNP	O
-	-	HYPH	O
methyl	methyl	NN	O
piperazine	piperazine	NN	O
12	12	CD	O
was	be	VBD	O
a	a	DT	O
medium	medium	JJ	O
potency	potency	NN	O
inhibitor	inhibitor	NN	O
KIs	ki	NNS	O
of	of	IN	O
33.5	33.5	CD	O
and	and	CC	O
33.5ânM	33.5ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
,	,	,	O
that	that	WDT	O
makes	make	VBZ	O
the	the	DT	O
latter	latter	JJ	O
more	more	RBR	O
selective	selective	JJ	O
against	against	IN	O
the	the	DT	O
Î²-CA3	Î²-CA3	NNP	O
isoform	isoform	NN	O
.	.	.	O

Interestingly	interestingly	RB	O
,	,	,	O
the	the	DT	O
substitution	substitution	NN	O
of	of	IN	O
the	the	DT	O
alkyl	alkyl	NN	O
ring	ring	NN	O
in	in	IN	O
9	9	CD	O
or	or	CC	O
12	12	CD	O
with	with	IN	O
a	a	DT	O
bis	bis	JJ	O
-	-	HYPH	O
alkyl	alkyl	NN	O
chain	chain	NN	O
,	,	,	O
as	as	IN	O
in	in	IN	O
compound	compound	NN	O
8	8	CD	O
,	,	,	O
or	or	CC	O
its	-PRON-	PRP$	O
modification	modification	NN	O
to	to	TO	O
produce	produce	VB	O
13	13	CD	O
and	and	CC	O
14	14	CD	O
,	,	,	O
resulted	result	VBD	O
in	in	IN	O
detrimental	detrimental	JJ	O
reductions	reduction	NNS	O
for	for	IN	O
the	the	DT	O
inhibition	inhibition	NN	O
potency	potency	NN	O
against	against	IN	O
the	the	DT	O
Î²-CA3	î²-ca3	NN	O
see	see	VB	O
Table	table	NN	O
1	1	CD	O
.	.	.	O

The	the	DT	O
lethal	lethal	JJ	O
concentrations	concentration	NNS	O
of	of	IN	O
the	the	DT	O
MTC	MTC	NNP	O
and	and	CC	O
DTC	DTC	NNP	O
1â14	1â14	CD	O
inhibitors	inhibitor	NNS	O
were	be	VBD	O
tested	test	VBN	O
on	on	IN	O
developing	develop	VBG	O
zebrafish	zebrafish	JJ	O
embryos	embryo	NNS	O
.	.	.	O

The	the	DT	O
lowest	low	JJS	O
concentration	concentration	NN	O
that	that	WDT	O
caused	cause	VBD	O
death	death	NN	O
of	of	IN	O
half	half	NN	O
of	of	IN	O
the	the	DT	O
embryos	embryo	NNS	O
was	be	VBD	O
reported	report	VBN	O
for	for	IN	O
the	the	DT	O
DTC	DTC	NNP	O
8	8	CD	O
i.e.	i.e.	FW	O
LD50	LD50	NNP	O
2âÎ¼M	2âî¼m	CD	O
,	,	,	O
which	which	WDT	O
was	be	VBD	O
therefore	therefore	RB	O
considered	consider	VBN	O
highly	highly	RB	O
toxic	toxic	JJ	O
and	and	CC	O
not	not	RB	O
suitable	suitable	JJ	O
for	for	IN	O
further	further	JJ	O
testing	testing	NN	O
in	in	IN	O
our	-PRON-	PRP$	O
studies	study	NNS	O
.	.	.	O

The	the	DT	O
LC50	LC50	NNP	O
values	value	NNS	O
of	of	IN	O
all	all	PDT	O
the	the	DT	O
compounds	compound	NNS	O
are	be	VBP	O
shown	show	VBN	O
in	in	IN	O
Table	table	NN	O
2	2	CD	O
.	.	.	O

The	the	DT	O
concentrations	concentration	NNS	O
do	do	VBP	O
not	not	RB	O
induce	induce	VB	O
any	any	DT	O
phenotypic	phenotypic	JJ	O
defects	defect	NNS	O
in	in	IN	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
at	at	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
exposure	exposure	NN	O
and	and	CC	O
safe	safe	JJ	O
for	for	IN	O
inhibition	inhibition	NN	O
studies	study	NNS	O
of	of	IN	O
M.	M.	NNP	O
marinum	marinum	NN	O
in	in	IN	O
zebrafish	zebrafish	JJ	B
.	.	.	O

The	the	DT	O
compound	compound	NN	O
12	12	CD	O
Fc14	Fc14	NNP	O
-	-	HYPH	O
584b	584b	NNPS	O
is	be	VBZ	O
screened	screen	VBN	O
for	for	IN	O
toxicity	toxicity	NN	O
and	and	CC	O
for	for	IN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
inhibition	inhibition	NN	O
studies	study	NNS	O
as	as	IN	O
reported	report	VBN	O
earlier	early	JJR	B
.	.	.	O

To	to	TO	O
assess	assess	VB	O
the	the	DT	O
toxic	toxic	JJ	O
effects	effect	NNS	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
on	on	IN	O
5-day	5-day	NNP	O
-	-	HYPH	O
old	old	JJ	O
zebrafish	zebrafish	NN	O
during	during	IN	O
development	development	NN	O
after	after	IN	O
4-day	4-day	CD	O
exposure	exposure	NN	O
to	to	IN	O
the	the	DT	O
compounds	compound	NNS	O
,	,	,	O
we	-PRON-	PRP	O
analysed	analyse	VBD	O
seven	seven	CD	O
observable	observable	JJ	O
phenotypic	phenotypic	JJ	O
parameters	parameter	NNS	O
Table	table	NN	O
3	3	CD	O
using	use	VBG	O
a	a	DT	O
stereo	stereo	NN	O
microscope	microscope	NN	O
and	and	CC	O
recorded	record	VBD	O
the	the	DT	O
observations	observation	NNS	O
for	for	IN	O
each	each	DT	O
group	group	NN	O
.	.	.	O

The	the	DT	O
zebrafish	zebrafish	NNP	O
treated	treat	VBN	O
with	with	IN	O
CAIs	CAIs	NNPS	O
were	be	VBD	O
compared	compare	VBN	O
with	with	IN	O
the	the	DT	O
control	control	NN	O
groups	group	NNS	O
not	not	RB	O
treated	treat	VBN	O
with	with	IN	O
any	any	DT	O
compound	compound	NN	O
or	or	CC	O
with	with	IN	O
1	1	CD	O
%	%	NN	O
DMSO	DMSO	NNS	O
.	.	.	O

The	the	DT	O
maximum	maximum	JJ	O
concentration	concentration	NN	O
of	of	IN	O
each	each	DT	O
compound	compound	NN	O
that	that	WDT	O
does	do	VBZ	O
not	not	RB	O
induce	induce	VB	O
any	any	DT	O
phenotypic	phenotypic	JJ	O
changes	change	NNS	O
in	in	IN	O
the	the	DT	O
larvae	larvae	NN	O
at	at	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
exposure	exposure	NN	O
was	be	VBD	O
considered	consider	VBN	O
as	as	IN	O
safe	safe	JJ	O
Table	table	NN	O
2	2	CD	O
and	and	CC	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
for	for	IN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
inhibition	inhibition	NN	O
of	of	IN	O
M.	M.	NNP	O
marinum	marinum	NN	O
in	in	IN	O
zebrafish	zebrafish	NNP	O
larvae	larvae	JJ	B
.	.	.	O

The	the	DT	O
images	image	NNS	O
in	in	IN	O
Figure	figure	NN	O
3	3	CD	O
show	show	NN	O
representative	representative	NN	O
larvae	larvae	NN	O
exposed	expose	VBN	O
to	to	IN	O
MTCs	mtc	NNS	O
and	and	CC	O
DTCs	dtc	NNS	O
in	in	IN	O
which	which	WDT	O
no	no	DT	O
apparent	apparent	JJ	O
phenotypic	phenotypic	JJ	O
defects	defect	NNS	O
were	be	VBD	O
observed	observe	VBN	O
except	except	IN	O
the	the	DT	O
compound	compound	NN	O
8	8	CD	O
that	that	WDT	O
showed	show	VBD	O
defects	defect	NNS	O
in	in	IN	O
the	the	DT	O
development	development	NN	O
of	of	IN	O
swim	swim	NN	O
bladder	bladder	NN	O
Figure	Figure	NNP	O
3	3	CD	O
,	,	,	O
arrow	arrow	NNP	O
.	.	.	O

DTC	DTC	NNP	O
12	12	CD	O
that	that	WDT	O
inhibited	inhibit	VBD	O
Mtb	Mtb	NNP	O
Î²-CAs	Î²-CAs	NNP	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
efficiently	efficiently	RB	O
in	in	IN	O
our	-PRON-	PRP$	O
earlier	early	JJR	O
studies	study	NNS	B
,	,	,	O
showed	show	VBD	O
similar	similar	JJ	O
results	result	NNS	O
and	and	CC	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
inhibition	inhibition	NN	O
of	of	IN	O
M.	M.	NNP	O
marinum	marinum	NN	O
in	in	IN	O
zebrafish	zebrafish	JJ	O
studies	study	NNS	B
.	.	.	O

Images	image	NNS	O
of	of	IN	O
zebrafish	zebrafish	JJ	O
larvae	larvae	NNP	O
treated	treat	VBN	O
with	with	IN	O
different	different	JJ	O
inhibitors	inhibitor	NNS	O
.	.	.	O

The	the	DT	O
identification	identification	NN	O
number	number	NN	O
of	of	IN	O
each	each	DT	O
compound	compound	NN	O
is	be	VBZ	O
in	in	IN	O
parenthesis	parenthesis	NN	O
.	.	.	O

The	the	DT	O
images	image	NNS	O
of	of	IN	O
the	the	DT	O
zebrafish	zebrafish	JJ	O
larvae	larvae	NNP	O
after	after	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
exposure	exposure	NN	O
to	to	IN	O
inhibitors	inhibitor	NNS	O
that	that	WDT	O
are	be	VBP	O
considered	consider	VBN	O
safe	safe	JJ	O
for	for	IN	O
inÂ	inÂ	NNP	O
vivo	vivo	NNP	O
use	use	NN	O
to	to	TO	O
inhibit	inhibit	VB	O
M.	M.	NNP	O
marinum	marinum	NN	O
growth	growth	NN	O
in	in	IN	O
larvae	larvae	JJ	B
.	.	.	O

The	the	DT	O
concentrations	concentration	NNS	O
of	of	IN	O
the	the	DT	O
MTCs	mtc	NNS	O
and	and	CC	O
DTCs	dtc	NNS	O
shown	show	VBN	O
here	here	RB	O
are	be	VBP	O
the	the	DT	O
highest	high	JJS	O
ones	one	NNS	O
generally	generally	RB	O
not	not	RB	O
inducing	induce	VBG	O
phenotypic	phenotypic	JJ	O
defects	defect	NNS	O
at	at	IN	O
the	the	DT	O
end	end	NN	O
of	of	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
exposure	exposure	NN	O
.	.	.	O

For	for	IN	O
compound	compound	NN	O
8	8	CD	O
,	,	,	O
even	even	RB	O
the	the	DT	O
lowest	low	JJS	O
concentration	concentration	NN	O
used	use	VBN	O
caused	cause	VBD	O
the	the	DT	O
absence	absence	NN	O
of	of	IN	O
swim	swim	NN	O
bladder	bladder	NN	O
arrow	arrow	NNP	O
,	,	,	O
suggesting	suggest	VBG	O
that	that	IN	O
this	this	DT	O
compound	compound	NN	O
is	be	VBZ	O
not	not	RB	O
suitable	suitable	JJ	O
for	for	IN	O
further	further	JJ	O
characterization	characterization	NN	B
.	.	.	O

Effect	effect	NN	O
of	of	IN	O
inhibitors	inhibitor	NNS	O
on	on	IN	O
phenotypic	phenotypic	JJ	O
parameters	parameter	NNS	O
of	of	IN	O
the	the	DT	O
larvae	larvae	NNP	O
5âdays	5âdays	CD	O
of	of	IN	O
after	after	IN	O
exposurea	exposurea	NNP	O
,	,	,	O
b.	b.	NNP	O
NA	NA	NNP	O
:	:	:	O
not	not	RB	O
applicable	applicable	JJ	O
.	.	.	O

The	the	DT	O
parameters	parameter	NNS	O
were	be	VBD	O
assessed	assess	VBN	O
at	at	IN	O
LC50	LC50	NNP	O
at	at	IN	O
5âday	5âday	CD	O
of	of	IN	O
exposure	exposure	NN	O
to	to	IN	O
the	the	DT	O
compounds	compound	NNS	O
.	.	.	O

The	the	DT	O
values	value	NNS	O
shown	show	VBN	O
are	be	VBP	O
in	in	IN	O
percent	percent	NN	O
of	of	IN	O
larvae	larvae	NNP	O
.	.	.	O

The	the	DT	O
compound	compound	NN	O
was	be	VBD	O
screened	screen	VBN	O
for	for	IN	O
toxicity	toxicity	NN	O
in	in	IN	O
our	-PRON-	PRP$	O
previous	previous	JJ	O
studies	study	NNS	O
.	.	.	O

Further	further	JJ	O
analyses	analysis	NNS	O
of	of	IN	O
the	the	DT	O
embryos	embryo	NNS	O
to	to	TO	O
assess	assess	VB	O
the	the	DT	O
toxicity	toxicity	NN	O
of	of	IN	O
compounds	compound	NNS	O
at	at	IN	O
the	the	DT	O
concentrations	concentration	NNS	O
that	that	WDT	O
are	be	VBP	O
considered	consider	VBN	O
as	as	IN	O
safe	safe	JJ	O
Table	table	NN	O
2	2	CD	O
on	on	IN	O
the	the	DT	O
observable	observable	JJ	O
phenotypic	phenotypic	JJ	O
parameters	parameter	NNS	O
showed	show	VBD	O
that	that	IN	O
some	some	DT	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
had	have	VBD	O
no	no	DT	O
significant	significant	JJ	O
effects	effect	NNS	O
on	on	IN	O
any	any	DT	O
of	of	IN	O
the	the	DT	O
parameters	parameter	NNS	O
assessed	assess	VBD	O
Table	table	NN	O
3	3	CD	O
.	.	.	O

The	the	DT	O
compounds	compound	NNS	O
that	that	WDT	O
were	be	VBD	O
considered	consider	VBN	O
toxic	toxic	JJ	O
,	,	,	O
showed	show	VBD	O
different	different	JJ	O
level	level	NN	O
of	of	IN	O
toxicity	toxicity	NN	O
by	by	IN	O
inducing	induce	VBG	O
high	high	JJ	O
mortality	mortality	NN	O
,	,	,	O
problem	problem	NN	O
with	with	IN	O
hatching	hatching	NN	O
,	,	,	O
oedema	oedema	NN	O
,	,	,	O
heartbeat	heartbeat	NN	O
,	,	,	O
yolk	yolk	NN	O
sac	sac	NN	O
utilisation	utilisation	NN	O
,	,	,	O
body	body	NN	O
shape	shape	NN	O
,	,	,	O
and	and	CC	O
swim	swim	VB	O
bladder	bladder	NN	O
development	development	NN	O
Figure	figure	NN	O
3	3	CD	O
as	as	IN	O
shown	show	VBN	O
in	in	IN	O
Table	table	NN	O
3	3	CD	O
.	.	.	O

We	-PRON-	PRP	O
analysed	analyse	VBD	O
the	the	DT	O
sections	section	NNS	O
of	of	IN	O
the	the	DT	O
zebrafish	zebrafish	NNPS	O
that	that	WDT	O
were	be	VBD	O
exposed	expose	VBN	O
to	to	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
which	which	WDT	O
did	do	VBD	O
not	not	RB	O
have	have	VB	O
any	any	DT	O
significant	significant	JJ	O
effect	effect	NN	O
on	on	IN	O
the	the	DT	O
phenotypic	phenotypic	JJ	O
parameters	parameter	NNS	O
Table	table	NN	O
2	2	CD	O
of	of	IN	O
the	the	DT	O
larvae	larvae	NN	O
at	at	IN	O
the	the	DT	O
end	end	NN	O
of	of	IN	O
5âdays	5âdays	CD	O
of	of	IN	O
exposure	exposure	NN	O
to	to	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
.	.	.	O

The	the	DT	O
histologically	histologically	RB	O
stained	stain	VBN	O
sections	section	NNS	O
of	of	IN	O
the	the	DT	O
inhibitor	inhibitor	NN	O
-	-	HYPH	O
treated	treat	VBN	O
larvae	larva	NNS	O
were	be	VBD	O
compared	compare	VBN	O
with	with	IN	O
the	the	DT	O
stained	stain	VBN	O
sections	section	NNS	O
of	of	IN	O
the	the	DT	O
control	control	NN	O
group	group	NN	O
larvae	larvae	NNP	O
.	.	.	O

None	none	NN	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
showed	show	VBD	O
any	any	DT	O
morphological	morphological	JJ	O
changes	change	NNS	O
of	of	IN	O
tissues	tissue	NNS	O
of	of	IN	O
the	the	DT	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
exposed	expose	VBN	O
to	to	IN	O
the	the	DT	O
MTCs	mtc	NNS	O
or	or	CC	O
DTCs	dtc	NNS	O
data	datum	NNS	O
not	not	RB	O
shown	show	VBN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
of	of	IN	O
the	the	DT	O
histological	histological	JJ	O
examination	examination	NN	O
suggest	suggest	VBP	O
that	that	IN	O
these	these	DT	O
inhibitors	inhibitor	NNS	O
cause	cause	VBP	O
no	no	DT	O
damage	damage	NN	O
to	to	IN	O
the	the	DT	O
internal	internal	JJ	O
tissues	tissue	NNS	O
at	at	IN	O
the	the	DT	O
concentrations	concentration	NNS	O
tested	test	VBN	O
and	and	CC	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
for	for	IN	O
further	further	JJ	O
characterisation	characterisation	NN	O
.	.	.	O

Zebrafish	zebrafish	JJ	O
embryos	embryo	NNS	O
are	be	VBP	O
easily	easily	RB	O
affected	affect	VBN	O
by	by	IN	O
chemical	chemical	JJ	O
compounds	compound	NNS	O
compared	compare	VBN	O
to	to	TO	O
adult	adult	VB	O
zebrafish	zebrafish	NNP	O
or	or	CC	O
other	other	JJ	O
animal	animal	NN	O
models	model	NNS	O
and	and	CC	O
are	be	VBP	O
hence	hence	RB	O
suitable	suitable	JJ	O
model	model	NN	O
organisms	organism	NNS	O
for	for	IN	O
assessing	assess	VBG	O
the	the	DT	O
subtle	subtle	JJ	O
toxic	toxic	JJ	O
effects	effect	NNS	O
of	of	IN	O
chemicals	chemical	NNS	B
,	,	,	B
.	.	.	O

In	in	IN	O
this	this	DT	O
study	study	NN	O
,	,	,	O
we	-PRON-	PRP	O
further	further	RB	O
assessed	assess	VBD	O
the	the	DT	O
subtle	subtle	JJ	O
toxic	toxic	JJ	O
effects	effect	NNS	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
by	by	IN	O
analysing	analyse	VBG	O
the	the	DT	O
swim	swim	NN	O
patterns	pattern	NNS	O
of	of	IN	O
the	the	DT	O
larvae	larvae	NN	O
during	during	IN	O
exposure	exposure	NN	O
to	to	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
at	at	IN	O
concentration	concentration	NN	O
that	that	WDT	O
are	be	VBP	O
considered	consider	VBN	O
as	as	IN	O
safe	safe	JJ	O
shown	show	VBN	O
in	in	IN	O
Table	table	NN	O
2	2	CD	O
.	.	.	O

The	the	DT	O
swim	swim	NN	O
pattern	pattern	NN	O
analysis	analysis	NN	O
showed	show	VBD	O
that	that	IN	O
11	11	CD	O
out	out	IN	O
of	of	IN	O
14	14	CD	O
compounds	compound	NNS	O
showed	show	VBD	O
no	no	DT	O
abnormal	abnormal	JJ	O
or	or	CC	O
ataxic	ataxic	JJ	O
movement	movement	NN	O
of	of	IN	O
the	the	DT	O
larvae	larva	NNS	O
that	that	WDT	O
were	be	VBD	O
exposed	expose	VBN	O
to	to	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
data	datum	NNS	O
now	now	RB	O
shown	show	VBN	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
most	most	JJS	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
that	that	WDT	O
efficiently	efficiently	RB	O
inhibit	inhibit	VBP	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
show	show	VB	O
no	no	DT	O
or	or	CC	O
minimal	minimal	JJ	O
toxicity	toxicity	NN	O
at	at	IN	O
relevant	relevant	JJ	O
concentrations	concentration	NNS	O
and	and	CC	O
are	be	VBP	O
thus	thus	RB	O
safe	safe	JJ	O
for	for	IN	O
further	further	JJ	O
characterisation	characterisation	NN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	B
,	,	,	B
Table	table	NN	O
4	4	CD	O
.	.	.	O

The	the	DT	O
compounds	compound	NNS	O
that	that	WDT	O
inhibit	inhibit	VBP	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
efficiently	efficiently	RB	O
and	and	CC	O
show	show	VB	O
minimal	minimal	JJ	O
toxicity	toxicity	NN	O
.	.	.	O

Inhibition	inhibition	NN	O
of	of	IN	O
Î²-CA3	Î²-CA3	NNP	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
.	.	.	O

The	the	DT	O
concentration	concentration	NN	O
that	that	WDT	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
for	for	IN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
studies	study	NNS	O
.	.	.	O

In	in	IN	O
this	this	DT	O
study	study	NN	O
,	,	,	O
we	-PRON-	PRP	O
investigated	investigate	VBD	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
14	14	CD	O
CAIs	cai	NNS	O
belonging	belong	VBG	O
to	to	IN	O
the	the	DT	O
MTC	MTC	NNP	O
and	and	CC	O
DTC	DTC	NNP	O
zinc	zinc	NN	O
binding	bind	VBG	O
moieties	moiety	NNS	O
possessing	possess	VBG	O
a	a	DT	O
variety	variety	NN	O
of	of	IN	O
scaffolds	scaffold	NNS	O
and	and	CC	O
intended	intend	VBN	O
as	as	IN	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
the	the	DT	O
Î²-CA3	î²-ca3	NN	O
from	from	IN	O
M.	M.	NNP	O
tuberculosis	tuberculosis	NN	O
.	.	.	O

All	all	DT	O
compounds	compound	NNS	O
were	be	VBD	O
investigated	investigate	VBN	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
for	for	IN	O
their	-PRON-	PRP$	O
inhibition	inhibition	NN	O
potencies	potency	NNS	O
against	against	IN	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
and	and	CC	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
human	human	JJ	O
hCA	hca	NN	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
.	.	.	O

The	the	DT	O
Mtb	Mtb	NNP	O
Î²-CA3	Î²-CA3	NNP	O
was	be	VBD	O
efficiently	efficiently	RB	O
inhibited	inhibit	VBN	O
by	by	IN	O
11	11	CD	O
of	of	IN	O
these	these	DT	O
derivatives	derivative	NNS	O
with	with	IN	O
KIs	ki	NNS	O
in	in	IN	O
the	the	DT	O
range	range	NN	O
of	of	IN	O
2.4â812ânM.	2.4â812ânm.	CD	O
We	-PRON-	PRP	O
evaluated	evaluate	VBD	O
these	these	DT	O
compounds	compound	NNS	O
for	for	IN	O
their	-PRON-	PRP$	O
toxic	toxic	JJ	O
effects	effect	NNS	O
on	on	IN	O
1â5	1â5	CD	O
dpf	dpf	NNP	O
zebrafish	zebrafish	JJ	O
larvae	larvae	NNP	O
.	.	.	O

The	the	DT	O
toxicological	toxicological	JJ	O
studies	study	NNS	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
compounds	compound	NNS	O
1	1	CD	O
,	,	,	O
3	3	CD	O
,	,	,	O
5	5	CD	O
,	,	,	O
7	7	CD	O
,	,	,	O
and	and	CC	O
10	10	CD	O
exhibited	exhibit	VBN	O
minimal	minimal	JJ	O
toxicity	toxicity	NN	O
and	and	CC	O
were	be	VBD	O
considered	consider	VBN	O
as	as	RB	O
safe	safe	JJ	O
for	for	IN	O
further	further	JJ	O
characterisation	characterisation	NN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
of	of	IN	O
the	the	DT	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
inhibition	inhibition	NN	O
and	and	CC	O
toxicological	toxicological	JJ	O
evaluation	evaluation	NN	O
studies	study	NNS	O
showed	show	VBD	O
that	that	IN	O
5	5	CD	O
compounds	compound	NNS	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
for	for	IN	O
inÂ	inÂ	NNP	O
vivo	vivo	NN	O
inhibition	inhibition	NN	O
of	of	IN	O
the	the	DT	O
M.	M.	NNP	O
marinum	marinum	NN	O
growth	growth	NN	O
in	in	IN	O
zebrafish	zebrafish	NNP	O
larvae	larvae	NNP	O
for	for	IN	O
further	further	JJ	O
preclinical	preclinical	JJ	O
characterisation	characterisation	NN	O
.	.	.	O

